Drugs / hyaluronidase human injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01848990 | Mar 2013 → Feb 2014 | type 1 diabetes mellitus | Halozyme Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hyaluronidase human injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01848990 ↗ |
| Route | Subcutaneous | “delivered at 150 units (U) through their insulin infusion cannula” NCT01848990 ↗ |